ATRC
NASD AtriCure, Inc.$56.37 ↑ +0.00 (+0.00%) Trading Up from the previous close of $56.37, $0.23 below the day’s high of $56.60
- YTD change
- +42.49%
- vs 20-day SMA
- -0.21%
- vs 200-day SMA
- +55.13%
Price ranges
Price & Performance
+27.18 (+93.11%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 36.8% away from all-time highs of $89.18
- ATRC is up 42% since the beginning of the year
- ATRC is up 62% over the past 12 months
- ATRC is up 7% over the past 1 month
- 9% of all ATRC investors are betting against ATRC
ATRC reads very good: price sits above one of the two key moving averages, the 12-month move is +62.3%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -3.44%
- vs 8-day SMA
- -2.07%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.